1,4,8-TRIHYDROXYNAPHTHALENE-1-O-BETA-D-[6'-O-(3'',5''-DIHYDROXY-4''-METHOXYBENZOYL]-GLUCOPYRANOSIDE
Compound with spectra: 1 NMR
![1,4,8-TRIHYDROXYNAPHTHALENE-1-O-BETA-D-[6'-O-(3'',5''-DIHYDROXY-4''-METHOXYBENZOYL]-GLUCOPYRANOSIDE](/api/compound/23nAZKhh03S.png?ph=true&h=300&w=458 "1,4,8-TRIHYDROXYNAPHTHALENE-1-O-BETA-D-[6'-O-(3'',5''-DIHYDROXY-4''-METHOXYBENZOYL]-GLUCOPYRANOSIDE")
| SpectraBase Compound ID | 23nAZKhh03S |
|---|---|
| InChI | InChI=1S/C24H24O12/c1-33-22-14(27)7-10(8-15(22)28)23(32)34-9-17-19(29)20(30)21(31)24(36-17)35-16-6-5-12(25)11-3-2-4-13(26)18(11)16/h2-8,17,19-21,24-31H,9H2,1H3/t17-,19-,20+,21-,24-/m0/s1 |
| InChIKey | AWBNNWFOUAJTSZ-LBUOEMMASA-N |
| Mol Weight | 504.44 g/mol |
| Molecular Formula | C24H24O12 |
| Exact Mass | 504.126776 g/mol |
| Enantiomer InChIKey | AWBNNWFOUAJTSZ-UKMCQSRUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
1,4,8-TRIHYDROXYNAPHTHALENE-1-O-BETA-D-[6'-O-(3'',4'',5''-TRIHYDROXYBENZOYL)]-GLUCOPYRANOSIDE
1,4,8-TRIHYDROXYNAPHTHALENE-1-O-BETA-D-GLUCOPYRANOSYL-(1->6)-ALPHA-L-ARABINOPYRANOSIDE
1,4,8-TRIHYDROXYNAPHTHALENE-1-O-D-GLUCOPYRANOSYL-(1->6)-BETA-D-XYLOPYRANOSIDE
1,4,8-TRIHYDROXYNAPHTHALENE-1-O-[ALPHA-L-ARABINOFURANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE]
NARINGENIN-4'-O-(6''-O-GALLOYL-BETA-D-GLUCOPYRANOSIDE)
4-O-{6-O-[4-O-(6-O-SYRINGYLOYL-BETA-D-GLUCOPYRANOSYL)-VANILLOYL]-BETA-D-GLUCOPYRANOSYL}-2-METHOXY-PARA-HYDROXYQUINONE
ACANTHOSIDE-C
2-(6-BENZOYL-BETA-GLUCOPYRANOSYLOXY)-7-[2-[(2-OXO-2-PHENYL)-ETHYL]-BENZOYL]-5-HYDROXYBENZYL_ALCOHOL
CAPPARILOSIDE-B;1H-INDOLE-3-ACETONITRILE-4-O-BETA-(6'-O-BETA-GLUCOPYRANOSYL)-GLUCOPYRANOSIDE
Naringenin 7-O-(6''-O-P-coumaryl)-B-D-glucoside
| Title | Journal or Book | Year |
|---|---|---|
| Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Ribonuclease H Activities by Constituents of Juglans mandshurica. | Chemical and Pharmaceutical Bulletin | 2000 |